INGN

Inogen Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 7/10
  • Momentum 2/10
Inogen sales and earnings growth
INGN Growth
Good
  • Revenue Y/Y 4.68%
  • EPS Y/Y 55.11%
  • FCF Y/Y -68.88%
Inogen gross and profit margin trends
INGN Profitability
Neutral
  • Gross margin 44.80%
  • EPS margin -7.30%
  • ROIC -25.80%
Inogen net debt vs free cash flow
INGN Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage NA

Inogen stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗